We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Strata Skin Sciences (SSKN) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Strata Skin Sciences (SSKN - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Strata Skin Sciences is a member of the Medical sector. This group includes 761 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. SSKN is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for SSKN's full-year earnings has moved 78.10% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, SSKN has gained about 48.78% so far this year. In comparison, Medical companies have returned an average of 2.52%. This means that Strata Skin Sciences is performing better than its sector in terms of year-to-date returns.
Breaking things down more, SSKN is a member of the Medical Info Systems industry, which includes 22 individual companies and currently sits at #173 in the Zacks Industry Rank. On average, this group has gained an average of 8.95% so far this year, meaning that SSKN is performing better in terms of year-to-date returns.
SSKN will likely be looking to continue its solid performance, so investors interested Medical stocks should continue to pay close attention to the company.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Strata Skin Sciences (SSKN) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Strata Skin Sciences (SSKN - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Strata Skin Sciences is a member of the Medical sector. This group includes 761 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. SSKN is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for SSKN's full-year earnings has moved 78.10% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, SSKN has gained about 48.78% so far this year. In comparison, Medical companies have returned an average of 2.52%. This means that Strata Skin Sciences is performing better than its sector in terms of year-to-date returns.
Breaking things down more, SSKN is a member of the Medical Info Systems industry, which includes 22 individual companies and currently sits at #173 in the Zacks Industry Rank. On average, this group has gained an average of 8.95% so far this year, meaning that SSKN is performing better in terms of year-to-date returns.
SSKN will likely be looking to continue its solid performance, so investors interested Medical stocks should continue to pay close attention to the company.